ABUS vs QCOM
Arbutus Biopharma Corp (ABUS) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the ABUS and QCOM stock pages for the full models.
Not investment advice.